Archive · 14 Sep 2025
India Warns Pharma Exporters Over Egypt Firm Payment Delays
India's government is warning Indian companies that export medicine to Egypt to be careful.
Some companies have not been paid on time by an Egyptian company called Biomed.
The Indian government advises exporters to ask for money upfront to avoid losing money.
This is because getting paid in a foreign country can be tricky and expensive.
India exports a lot of medicine, so this warning is important to protect the businesses.
Indian embassy in Cairo issued an advisory to pharma exporters.
The advisory concerns Biomed For Pharmaceutical Industries in Egypt.
Several Indian companies have faced payment delays from Biomed.
The advisory recommends seeking advance payments for exports.
India is a major global exporter of pharmaceuticals.
- Who
- Indian pharmaceutical exporters
- What
- A cautionary advisory regarding payment delays from an Egyptian firm
- When
- Not specified in the article, but the advisory was recently issued.
- Where
- Egypt
- Why
- To mitigate financial risks and potential losses for exporters.
- Company of Concern
- Biomed For Pharmaceutical Industries
- Location
- Egypt
- Action
- Advisory issued by Indian embassy in Cairo
- Advice
- Demand advance payments
- India's Pharma Export Share
- 20% of global exports
- India Pharma Exports to Egypt 2024
- $42.74 million